XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Net revenue $ 446,753 $ 441,245
Operating expenses:    
Practice salaries and benefits 319,012 316,279
Practice supplies and other operating expenses 22,212 23,842
General and administrative expenses 66,516 67,442
Depreciation and amortization 8,031 6,803
Transformational and restructuring related expenses 4,878 16,076
Total operating expenses 420,649 430,442
Income from operations 26,104 10,803
Investment and other income (expense) 5,967 (1,046)
Interest expense (17,645) (27,665)
Loss on early extinguishment of debt (14,532) 0
Equity in earnings of unconsolidated affiliate 495 494
Total non-operating expenses (25,715) (28,217)
Income (loss) from continuing operations before income taxes 389 (17,414)
Income tax benefit (provision) 4,955 (1,085)
Income (loss) from continuing operations 5,344 (18,499)
Income (loss) from discontinued operations, net of tax 12,290 (213)
Net income (loss) 17,634 (18,712)
Net loss attributable to noncontrolling interest [1] 8  
Net income (loss) $ 17,642 $ (18,712)
Income (loss) from continuing operations:    
Basic $ 0.06 $ (0.22)
Diluted 0.06 (0.22)
Income from discontinued operations:    
Basic 0.15  
Diluted 0.15  
Net income (loss) attributable to Mednax, Inc.:    
Basic 0.21 (0.22)
Diluted $ 0.21 $ (0.22)
Weighted average common shares:    
Basic 84,526 82,799
Diluted [2] 85,491 82,799
[1] Noncontrolling interest in 2021 is presented within retained deficit as the balance is immaterial.
[2] Due to a loss from continuing operations for the three months ended March 31, 2021, no incremental shares are included because the effect would be antidilutive.